Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,319,999
+$946,063 QoQ
Shares Held
209,068
+19.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#207
of 1,016 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026&PARTNERS holds $18,450,769 across 16 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
67,603 | $4,857,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,447 | $3,493,178 | |
| 3 | VTRS |
Viatris Inc
This page
|
209,068 | $3,319,999 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
13,769 | $1,527,532 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
29,413 | $996,512 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
29,984 | $737,906 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
13,127 | $620,513 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
37,853 | $606,783 |
All Filings in VTRS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,319,999 | 209,068 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,373,936 | 175,717 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,081,689 | 167,204 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,603,354 | 161,955 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,434,247 | 160,610 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $732,023 | 84,044 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $696,191 | 55,919 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $540,631 | 46,566 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $243,182 | 22,877 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||